CareRx (TSE:CRRX) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
CareRx Corporation reported a mixed financial performance for Q2 2024 with a revenue of $92.0 million and an increased adjusted EBITDA of $7.5 million, despite facing a net loss of $1.4 million. The company remains committed to improving productivity and managing costs, while capitalizing on growth opportunities in the seniors living sector.
For further insights into TSE:CRRX stock, check out TipRanks’ Stock Analysis page.